Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
Wall Street
Price Targets
ONCO3 Price Targets Summary
Oncoclinicas do Brasil Servicos Medicos SA
According to Wall Street analysts, the average 1-year price target for
ONCO3
is 17.35 BRL
with a low forecast of 13.13 BRL and a high forecast of 24.15 BRL.
Revenue
Forecast
Revenue Estimate
Oncoclinicas do Brasil Servicos Medicos SA
For the last 4 years the
compound annual growth rate for
Oncoclinicas do Brasil Servicos Medicos SA's revenue is
34%.
The projected
CAGR
for the next 3 years is
18%.
Operating Income
Forecast
Operating Income Estimate
Oncoclinicas do Brasil Servicos Medicos SA
For the last 4 years the
compound annual growth rate for
Oncoclinicas do Brasil Servicos Medicos SA's operating income is
59%.
The projected
CAGR
for the next 2 years is
36%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ONCO3's stock price target?
Price Target
17.35
BRL
According to Wall Street analysts, the average 1-year price target for
ONCO3
is 17.35 BRL
with a low forecast of 13.13 BRL and a high forecast of 24.15 BRL.
What is Oncoclinicas do Brasil Servicos Medicos SA's Revenue forecast?
Projected CAGR
18%
For the last 4 years the
compound annual growth rate for
Oncoclinicas do Brasil Servicos Medicos SA's revenue is
34%.
The projected
CAGR
for the next 3 years is
18%.
What is Oncoclinicas do Brasil Servicos Medicos SA's Operating Income forecast?
Projected CAGR
36%
For the last 4 years the
compound annual growth rate for
Oncoclinicas do Brasil Servicos Medicos SA's operating income is
59%.
The projected
CAGR
for the next 2 years is
36%.
What is Oncoclinicas do Brasil Servicos Medicos SA's Net Income forecast?
Projected CAGR
53%
The
compound annual growth rate
of Oncoclinicas do Brasil Servicos Medicos SA's net income for the next 2 years is
53%.
You don't have any saved screeners yet
